Skip to main content
INKT
NASDAQ Life Sciences

MiNK 10-Q: Going-Concern Warning, $7.5M Cash, First $0.2M Product Revenue

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$10.081
Mkt Cap
$51.441M
52W Low
$8.48
52W High
$16.927
52W Position info
19% above low
Off High info
40% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

INKT sits 19% above its 52-week low of $8.48 on light trading volume (0.2× avg).

Summary

MiNK's Q3 10-Q carries a going-concern warning, with $7.5 million of cash against $5.1 million of nine-month operating burn, offset only by a first $0.2 million of named-patient product revenue.


Key Events · Earnings and Guidance · INKT

  • Going-Concern Warning Disclosed

    The 10-Q states substantial doubt exists about MiNK's ability to continue as a going concern for one year after the filing date, absent additional funding.

  • Cash Down to $7.5 Million

    Cash and cash equivalents fell to $7.5 million at September 30, 2026 from $13.4 million at December 31, 2025, while net cash used in operations rose to $5.1 million from $3.9 million a year earlier.

  • First Product Revenue: $0.2 Million

    MiNK recognized its first pre-commercial product revenue, $0.2 million, from agenT-797 supplied on a paid, per-patient basis under the Brazil named-patient access program.

  • ATM Remains the Funding Lever

    Under the B. Riley Sales Agreement, 313,478 shares were sold in the nine months for $4.4 million net proceeds, with no Q3 sales and roughly $30.6 million still available.


Analysis · INKT · Life Sciences

The Q3 numbers were already out on 2026-11-11, but the full 10-Q is where the going-concern language lands: management states substantial doubt exists about MiNK's ability to continue as a going concern for one year after filing. Cash fell to $7.5 million from $13.4 million at year-end 2025, and operating burn ran $5.1 million for the nine months versus $3.9 million a year earlier — roughly a year of runway only if the ATM keeps producing. Against that, the company booked its first $0.2 million of product revenue from agenT-797 in Brazil's named-patient program, a small but real commercial proof point. The $5.0 million Agenus note was repaid in January 2026, but $16.3 million is still owed to related parties. The funding gap is the story: expect further ATM sales or a partnership to bridge it.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INKT was trading at $10.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $51.4M. The 52-week trading range was $8.48 to $16.93. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INKT - Latest Insights

INKT
Nov 11, 2026, 9:31 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $10.00
Real-time Price: $10.08 info
Change: +$0.0805 (+0.81%) info
Market Cap: $51.441M info
INKT
Sep 30, 2026, 7:57 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $15.93
Real-time Price: $10.08 info
Change: -$5.85 (-37%) info
Market Cap: $51.441M info
INKT
Aug 13, 2026, 7:40 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.08
Real-time Price: $10.08 info
Change: -$0.9995 (-9%) info
Market Cap: $51.441M info
INKT
Aug 13, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $11.08
Real-time Price: $10.08 info
Change: -$0.9995 (-9%) info
Market Cap: $51.441M info
INKT
May 15, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $10.95
Real-time Price: $10.08 info
Change: -$0.8705 (-8%) info
Market Cap: $51.441M info